Aperiam Bio is a startup based in the United States, 2 tracked investors.
Aperiam Bio is a company headquartered in the United States. Brouky records 2 investors associated with the company.
Aperiam Bio develops hyperfolding variants of proteins using computational algorithms to improve expression, solubility, and activity, enabling the manufacture of stable enzymes and therapeutics for applications in cosmetics and pulmonary biologics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.